Abstract
ABSTRACT This study was undertaken to determine the prevalence of use, reasons for use, amounts and methods used, and perceived effectiveness of cannabis and dronabinol among persons living with HIV/AIDS in Canada. Cross-sectional anonymous self-administered questionnaire study. Four hundred patients were consecutively recruited from 3 primary care HIV clinics in Toronto, Ottawa and Montreal, and 50 questionnaires were distributed to PHAs (persons having AIDS) at one “cannabis compassion club.” Responses were received from 160 clinic patients and 19 compassion club patients (40% response rate). Of 160 PHAs attending the HIV clinics, 59 patients (37.3%, 95% CI 29.5–45.1%) reported current use of cannabis. Of 19 compassion club clients, all reported current use of cannabis. Cannabis was most commonly used for stress relief and loss of appetite in both populations, in addition to relief of stress and nausea. Side effects included “high” and dry mouth. Dronabinol and cannabis were also reported to relieve adv...
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
